The Latest Breaking News from STEM

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Summertime treats, booming sound systems, and good vibes are tools of survival in a joy-starved world.

“They basically told me there was nothing wrong with me. I wasn’t going to sit there for hours to be told nothing was wrong.”

Gareth Dixon started to suffer from chest pains and, after a 20-hour wait at Warrington Hospital’s A&E department, received a terminal diagnosis that saw his wife break down crying

A former Kentucky police detective intends to plead guilty to a civil rights charge stemming from the botched drug raid that led to Breonna Taylor's fatal shooting in 2020

Horror stories of burnout, demoralisation and ever-growing workloads have become all too common as the education system faces an "unprecedented" teacher drought that's the "single biggest issue" facing all school sectors.

Children, even some who are too young for school, know you can’t make a baby without sperm and an egg. But a team of researchers in Israel have called into question the basics of what we teach children about the birds and the bees, and created a mouse embryo using…

An 11-year-old boy from Bangladesh, who was diagnosed with tumour in the brain stem, underwent surgery in Chennai hospital

New research pins baldness to a single chemical